Zdrowie i gospodarka · 10/03/2006

FDA Releases Draft Guidance for Industry on Clinical Data Needed to Support Licensure of Trivalent Inactivated Influenza Vaccines

The Food and Drug Administration (FDA) has made available a draft document outlining the clinical data required to support the licensure of new trivalent inactivated influenza vaccines, aiming to expedite the approval process for these vaccines.